Erratum to: Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma

Japanese Patients ◽

Efficacy And Safety ◽

Immune Oncology

Efficacy and safety of third- and fourth-line targeted therapy in japanese patients with metastatic renal cell carcinoma: A retrospective analysis

Indian Journal of Urology ◽

10.4103/iju.iju_248_17 ◽

2018 ◽

Vol 34 (2) ◽

pp. 127 ◽

Cited By ~ 2

Author(s):

Negishi Takahito ◽

Nagase Kei ◽

Iwai Hidenori ◽

Furubayashi Nobuki ◽

Taguchi Kenichi ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Retrospective Analysis ◽

Renal Cell ◽

Japanese Patients ◽

Efficacy And Safety

Molecular-targeted Therapy and Surgery May Prolong Survival of Renal Cell Carcinoma Patients with Bone Metastasis: A Multi-institutional Retrospective Study in Japan

Anticancer Research ◽

10.21873/anticanres.11136 ◽

2016 ◽

Vol 36 (10) ◽

pp. 5531-5536 ◽

Cited By ~ 5

Author(s):

HIROSHI KITAMURA ◽

ATSUSHI TAKAHASHI ◽

FUMIYASU TAKEI ◽

HIROSHI HOTTA ◽

NORIOMI MIYAO ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Retrospective Study ◽

Targeted Therapy ◽

Bone Metastasis ◽

Cell Carcinoma ◽

Renal Cell ◽

Molecular Targeted Therapy

Efficacy and Safety of Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients from the Global Randomized Phase 3 AXIS Trial

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyt054 ◽

2013 ◽

Vol 43 (6) ◽

pp. 616-628 ◽

Cited By ~ 47

Author(s):

T. Ueda ◽

H. Uemura ◽

Y. Tomita ◽

T. Tsukamoto ◽

H. Kanayama ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Subgroup Analysis ◽

Renal Cell ◽

Japanese Patients ◽

Efficacy And Safety ◽

Phase 3

DI-006 Prescription pattern of molecular targeted therapy in metastatic renal cell carcinoma

European Journal of Hospital Pharmacy ◽

10.1136/ejhpharm-2013-000436.177 ◽

2014 ◽

Vol 21 (Suppl 1) ◽

pp. A72.1-A72

Author(s):

P Amorós ◽

C Bastida ◽

F Do Pazo ◽

N Creus ◽

C Codina

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Renal Cell ◽

Prescription Pattern

The impact of change in serum C-reactive protein level on the prediction of effects of molecular targeted therapy in patients with metastatic renal cell carcinoma

BJU International ◽

10.1111/bju.13260 ◽

2015 ◽

Vol 117 (6B) ◽

pp. E67-E74 ◽

Cited By ~ 17

Author(s):

Jun Teishima ◽

Kohei Kobatake ◽

Hiroyuki Kitano ◽

Hirotaka Nagamatsu ◽

Kousuke Sadahide ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Protein Level ◽

Renal Cell ◽

C Reactive Protein ◽

Reactive Protein ◽

The Impact

Long‑term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report

Molecular and Clinical Oncology ◽

10.3892/mco.2021.2233 ◽

2021 ◽

Vol 14 (4) ◽

Author(s):

Yuichi Arai ◽

Yosuke Kitamura ◽

Kosuke Miyai ◽

Mina Hatanaka ◽

Hirofumi Hashimoto ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Case Report ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Renal Cell ◽

Local Treatment ◽

Papillary Renal Cell Carcinoma

Early tumor shrinkage as a predictive factor of metastatic renal cell carcinoma in molecular targeted therapy: A single institutional study

Molecular and Clinical Oncology ◽

10.3892/mco.2018.1762 ◽

2018 ◽

Author(s):

Suguru Shirotake ◽

Hideyuki Kondo ◽

Takashi Okabe ◽

Soichi Makino ◽

Ryuichiro Araki ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Predictive Factor ◽

Renal Cell ◽

Tumor Shrinkage ◽

Early Tumor Shrinkage ◽

Early Tumor

Editorial Comment from Dr Saito to Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy

International Journal of Urology ◽

10.1111/j.1442-2042.2012.03136.x ◽

2012 ◽

Vol 19 (12) ◽

pp. 1059-1059

Author(s):

Kazutaka Saito

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Editorial Comment ◽

Cell Carcinoma ◽

Renal Cell ◽

Molecular Targeted Therapy

7147 Efficacy and safety of long-term use of sorafenib: final report of a phase II trial of sorafenib in Japanese patients with unresectable/metastatic renal cell carcinoma

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71480-6 ◽

2009 ◽

Vol 7 (2) ◽

pp. 437-438 ◽

Cited By ~ 1

Author(s):

H. Akaza ◽

S. Naito ◽

T. Tsukamoto ◽

M. Murai ◽

K. Fukino

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Phase Ii Trial ◽

Japanese Patients ◽

Final Report ◽

Efficacy And Safety

FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-018-3542-7 ◽

2018 ◽

Vol 81 (4) ◽

pp. 739-744 ◽

Cited By ~ 4

Author(s):

Noboru Nakaigawa ◽

Keiichi Kondo ◽

Tomohiro Kaneta ◽

Ukihide Tateishi ◽

Ryogo Minamimoto ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Fdg Pet ◽

Renal Cell ◽

Pet Ct ◽

Fdg Pet Ct